Together, seven-plus years ago now, we watched the beginning of a downturn that cut the S&P 500 in half and dropped the Nasdaq nearly 80% off its highs. It was a maddening time for investors. Telecom and energy executives were caught with their hands in the corporate cookie jar. Technology shares plummeted, with hundreds of companies vanishing from sight. Very few bear markets in U.S. history have hurt so much. Sun Microsystems
Just how painful was it? Ask Nobel Prize-winning psychologist Daniel Kahneman, who proved that humans are innately loss-averse, particularly when it comes to money. Losses hurt us emotionally far more than gains give us pleasure. Naturally, then, those massive declines crippled tens of thousands of investors, many of whom will -- sadly -- never throw the one-two punch of savings and investment again.
It doesn't have to be that way.
Win with moderate risk
The solution is not to bail out of the market altogether, nor to seek shelter exclusively in bond funds. With the right perspective and useful tools, you can strengthen your stomach and beat the market -- because you'll do so without assuming huge risk. I know that's true because it's being done every year by the world's master investors -- Buffett and Lynch, Tillinghast and Miller, and more.
Those who take the biggest risks and buy what's hot today usually take the biggest hits in down markets. In the meantime, a host of methodical, smart, and contrarian investors ring up great returns, even through tough markets, by adhering to Warren Buffett's first rule of investing: Preserve capital.
Today, I want to focus on one sweet way to preserve capital and beat the market. The general principle is simple: Buy stocks that have paid uninterrupted dividends for years.
Consistency to victory
Let's investigate this idea by looking first at Procter & Gamble
Then there's Colgate-Palmolive
This sort of investing success is happening every day in our Motley Fool Income Investor advisory service. Using a combination of outsized yields and capital gains, the service has beaten the market by more than 9 percentage points since its 2003 inception.
But we're not picking just any old high-yielder. We believe that to outperform the market, you have to find financially strong, well-managed, undervalued companies that pay dividends. Why take a chance on Joe's Next-Generation e-Hot Dog Stand -- with its jumpy beta, battered balance sheet, and 50-50 chance of going bankrupt -- when you could invest in a stable ship that returns profits to shareholders and provides capital returns over the long term?
It's a tried-and-true formula, and if you follow it, you'll have the stomach to beat the market.
A monster income investment
Finding great dividend payers isn't as simple as merely screening for yields. As with any investment, it's crucial to scrutinize a dividend payer's financial statements, management team, and business model. Determine how the dividends are being financed, what the payout ratio is and how that might affect future growth, and what the prospects for dividend increases may be. This is exactly what Income Investor does each month for its members.
Let's look at one of our favorite monster stocks: Income Investor recommendation Diageo in May 2004. At the time, the liquor leader was trading for $53. Using a discounted cash flow model, we pegged its fair value closer to $61 -- later revising that valuation upward. Today the stock trades at $78.
There are loads of great dividend-paying stocks, but they're not the market's most popular. In fact, you usually have to go digging to find them. But to view our two newest picks and favorite stocks for new money now, click here to join Income Investor. There's no obligation to subscribe, and maybe -- just maybe -- we'll come through this crazy market without any massive losses.
This article was originally published as "Do You Have the Stomach to Beat the Market?" on June 10, 2005. It has been updated.
Tim Hanson does not own shares of any company mentioned in this article. Pfizer and Colgate-Palmolive are Inside Value recommendations. Pfizer and Diageo are Income Investor selections. No Fool is too cool for disclosure.
More from The Motley Fool
GM Proved Doubters Wrong in 2017 With a Strong Crossover Lineup
GM surprised the market when it announced strong guidance thanks to a revamped line of crossovers and SUVs. Better still, it delivered on the promises.
Ford's Behind-the-Scenes Focus on Data
Ford’s recent partnerships and small-scale tests could bode well for the future.
Ford's Tumultuous 2017
Ford’s stock languished behind GM throughout 2017. Will 2018 be a turnaround year?